[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-345656-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-345656-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","large-scale-and-high-resolution-mass-spectrometry-based-proteomics-defines-molecular-subtypes-of-nasopharyngeal-carcinoma-for-therapeutic-targeting","Large-scale and high-resolution mass spectrometry-based proteomics defines molecular subtypes of nasopharyngeal carcinoma for therapeutic targeting","","Challenges in precise diagnosis and treatment of nasopharyngeal carcinoma (NPC) persist due to limited multi-omics molecular classification and insufficient targeted therapies. Large-scale proteomic and phosphoproteomic profiling of NPC and non-cancerous nasopharyngeal tissues identified dysregulated proteins and phosphorylation networks, enabling classification into two molecular subtypes (S1, S2) with distinct clinical heterogeneity. S2 showed stronger immune-suppressive traits. Using subtype-enriched proteomic data, robust diagnostic and prognostic models were built. Computational drug repurposing and experimental validation identified Panobinostat as an effective anti-tumor agent, inhibiting MYC and impairing homologous recombination DNA repair, increasing DNA double-strand breaks, and enhancing efficacy with radiotherapy. ",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/large-scale-and-high-resolution-mass-spectrometry-based-proteomics-defines-molecular-subtypes-of-nasopharyngeal-carcinoma-for-therapeutic-targeting/345656/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/large-scale-and-high-resolution-mass-spectrometry-based-proteomics-defines-molecular-subtypes-of-nasopharyngeal-carcinoma-for-therapeutic-targeting/345656.png","ImageObject",300,407,{"name":42,"@type":43},"Rowan","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How were molecular subtypes of NPC identified in this study?","Question",{"text":63,"@type":64},"Proteomic and phosphoproteomic analyses of NPC and non-cancerous nasopharyngeal tissues were used to define dysregulated proteins and phosphorylation networks, which enabled classification into two molecular subtypes (S1 and S2).","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What distinguishes the S2 subtype from S1?",{"text":68,"@type":64},"The S2 subtype exhibited stronger immune suppressive characteristics, reflecting clinically relevant heterogeneity between the two subtypes.",{"name":70,"@type":61,"acceptedAnswer":71},"Why is Panobinostat highlighted as a therapeutic candidate?",{"text":72,"@type":64},"Panobinostat showed potent anti-tumor activity in vitro and in vivo and mechanistically inhibited MYC expression, reducing transcriptional activation of homologous recombination DNA repair components and increasing DNA double-strand breaks.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},345656,1790138343,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","Signal Transduction [and Targeted Therapy](and Targeted Therapy www.nature.com/sigtrans)[ www.nature.com/sigtrans](and Targeted Therapy www.nature.com/sigtrans)  \nARTICLE OPEN  \nLarge-scale and high-resolution mass spectrometry-based proteomics deﬁnes molecular subtypes of nasopharyngeal carcinoma for therapeutic targeting  \nYi-Ping Wu1,2, Yao-Hui He 3,4,5, Guo-Sheng Hu3,4,6, Zhi-Qin Li2, Qing-Wen Li 1,2, Xiao-Tong Chen 1,2, Hui-Ying Ling 1,2, Wen Liu 1,2,3,4,7 ✉ and Qin Lin 1,2 ✉  \n\n| | Challenges in the precise diagnosis and treatment of nasopharyngeal carcinoma (NPC) remain, mainly due to the absence of a multi-omics-based molecular classiﬁcation and effective targeted therapies. In this study, we performed proteomic and phosphoproteomic analyses of NPC and non-cancerous nasopharyngeal tissues to identify key dysregulated proteins and phosphorylation networks. Based on these proﬁles, we classiﬁed NPC into two distinct molecular subtypes: S1 and S2, which exhibit signiﬁcant clinical heterogeneity. Notably, the S2 subtype displayed stronger immune suppressive characteristics. By leveraging proteomic data from both cancerous and non-cancerous tissues, as well as from the two molecular subtypes, we developed robust diagnostic and prognostic models. Through computational drug repurposing and experimental validation, we identiﬁed Panobinostat, a pan-histone deacetylase inhibitor, as a potent anti-tumor agent for NPC, demonstrating efﬁcacy in both in vitro and in vivo models. Mechanistically, Panobinostat inhibits MYC expression, thereby suppressing the transcriptional activation of key components in the homologous recombination (HR) DNA repair pathway. This reduction in transcriptional activation impairs HR repair efﬁciency and leads to the accumulation of DNA double-strand breaks (DSBs) . Furthermore, combination therapy with Panobinostat and radiotherapy produced a synergistic effect, signiﬁcantly enhancing NPC suppression. Additionally, we predicted and validated potential drugs for targeting the S2 subtype of NPC. In conclusion, we identiﬁed molecular subtypes of NPC, constructed preliminary diagnostic and prognostic marker panels, and observed the therapeutic potential of Panobinostat, as amonotherapy and in combination with radiotherapy. These ﬁndings provide a solid foundation for precision diagnosis, prognostic | |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  | stratiﬁcation, and personalized treatment strategies for NPC. |  |\n|  |  |  |\n|  |  |  |\n|  | Signal Transduction and Targeted Therapy (2026)11:244 ; [https://doi.org/10.1038/s41392-026-02742-0](https://doi.org/10.1038/s41392-026-02742-0) |  |\n|  |  |  |\n\nINTRODUCTION  \nNasopharyngeal carcinoma (NPC) is a malignant epithelial tumor that arises from the nasopharyngeal mucosal lining and has wellestablished etiological links to Epstein-Barr virus (EBV) infection.1,2 Radiotherapy is the primary treatment for NPC, given its high sensitivity to ionizing radiation. The current paradigm of intensitymodulated radiotherapy (IMRT) combined with platinum-based concurrent chemoradiotherapy has achieved 5-year local control rates exceeding 90% in clinical trials.3,4 However, a high proportion of patients present with locally advanced disease at initial diagnosis, leading to approximately 30% experiencing local recurrence and distant metastasis, which ultimately results in treatment failure.5  \nOmics technologies can elucidate molecular mechanisms challenging to address through genomic approaches. Numerous comprehensive genomic proﬁling studies have identiﬁed frequent  \nmutations in several NPC driver genes (e.g., TP53, TRAF3), most of which are located in the NF-κB pathway, underscoring its central role in NPC oncogenesis.6–10 These studies also revealed high tumor mutational burden and increased genomic instability in NPC. However, chan","cbCainX8RaIpU4iw","https://ap.wps.com/l/cbCainX8RaIpU4iw","pdf",7202920,18,"English","# Introduction\n## Challenges in NPC diagnosis and treatment\n## Omics approaches and proteomic rationale\n## Study aim and overview","[{\"question\":\"How were molecular subtypes of NPC identified in this study?\",\"answer\":\"Proteomic and phosphoproteomic analyses of NPC and non-cancerous nasopharyngeal tissues were used to define dysregulated proteins and phosphorylation networks, which enabled classification into two molecular subtypes (S1 and S2).\"},{\"question\":\"What distinguishes the S2 subtype from S1?\",\"answer\":\"The S2 subtype exhibited stronger immune suppressive characteristics, reflecting clinically relevant heterogeneity between the two subtypes.\"},{\"question\":\"Why is Panobinostat highlighted as a therapeutic candidate?\",\"answer\":\"Panobinostat showed potent anti-tumor activity in vitro and in vivo and mechanistically inhibited MYC expression, reducing transcriptional activation of homologous recombination DNA repair components and increasing DNA double-strand breaks.\"}]","Large-scale and high-resolution mass spectrometry-based proteomics defines molecular subtypes of nasopharyngeal carcinoma for therapeutic targeting | PDF",1790058472,45,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/74cc18cff0a2881c3d916d840a6caa04.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5e5db93168943e8437ce3e763ee4596b.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0e4102b34474b52f1c968dbb4c0e6e4e.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/754a7e735922e23d7d96dd68009ab01d.webp",980,1301]